Novartis AG Materiality Assessment Webinar: Dialogue Matters Transcript
I'm the moderator for today's Novartis Materiality Assessment 2021 kickoff webinar, and it's a pleasure to welcome you all to today's discussion. The next slide will give us the agenda for our discussion. And you can see that we'll be taking a look at why materiality assessment is important, what has Novartis achieved, where are they heading, and also there will be an opportunity, as usual, to hear from all of you with your questions and comments. The next slide is just some logistics for us. The duration of the meeting will be an hour. (Operator Instructions)
Now let me turn to our speakers and introduce our panel. We have a distinguished group of speakers from Novartis. On the next slide, we'll show some photos of them. We'll be hearing first from Patrice Matchaba, who's the Head of U.S. Corporate Responsibility and President of the Novartis U.S. Foundation; Dr. Lutz Hegemann, who's the Group Head of Corporate Affairs and Global Health; Samir Shah, the Head of Investor Relations; and Carrie Scott, the Head of the ESG Management Office.
So
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |